The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...

In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.